Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KE Holdings Inc (BEKE) vs Hims and Hers Health Inc (HIMS) Price & Performance

KE Holdings IncTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

KE Holdings Inc vs Hims and Hers Health Inc — how do they compare? KE Holdings Inc trades at $17.32 (market cap $18.92B), while Hims and Hers Health Inc trades at $29.88 (market cap $7.12B). The key difference: KE Holdings Inc is far larger — about 2.7× Hims and Hers Health Inc's market cap, and KE Holdings Inc pays a 1.63% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

BEKEHIMS
Market Cap
$18.92B$7.12B
Sector
TechnologyHealth
52-Week High
$20.36$62.76
52-Week Low
$14.26$14.52
Enterprise Value
$14.66B$7.82B
Dividend Yield
1.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KE Holdings Inc

BEKE trades at $17.23, down 2.38% today, with a bullish technical signal supported by moving averages. The company reported strong Q1 2026 results, beating EPS estimates with $0.20 vs. $0.14 expected, while revenue declined to $90.1B in 2026 from $94.6B in 2025. Analyst sentiment remains overwhelmingly positive with 91.67% buy ratings. Cash flow trends show improvement with operating cash flow turning positive in 2026 at $2.1B.

The outlook appears favorable with improving profitability and strong analyst support, though risks include revenue contraction and China's property market exposure. The stock's current valuation at P/E 38.53 appears elevated but is supported by earnings growth potential and market leadership position in Chinese housing services.

Hims and Hers Health Inc

HIMS stock declined 7.11% to $29.51 following mixed Q2 2026 results, where revenue beat expectations but the company posted a wider-than-expected loss. The technical picture is neutral with bearish moving average signals, while fundamentals show strong revenue growth but deteriorating margins. Recent news highlights margin pressure from GLP-1 drug investments and an FTC investigation, creating investor uncertainty despite raised revenue guidance.

The outlook remains cautious as strong subscriber growth and AI initiatives are offset by profitability challenges and regulatory scrutiny. Investment opportunity exists in the company's expanding global footprint and raised revenue targets, but risks include margin compression, negative cash flow trends, and ongoing legal investigations that could pressure the stock near-term.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KE Holdings Inc

KE Holdings (Beike) is China’s leading platform for housing transactions and services. It operates the Lianjia brand and uses data-driven technology to facilitate home sales, rentals, and home renovation services.

Read more on BEKE

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS